Webinar ESPRM: Jean-François Kaux

Online, 24 gennaio 2024

 

iscrizione gratuita (link)                                flyer

 

è possibile rivederlo tramite questo link

 

Webinar January 24, 2024 – 7 pm cet

JEAN-FRANÇOIS KAUX
Is the Head of Department of Physical Medicine, Functional Rehabilitation and Sports Traumatology at the University Hospital of Liège and Professor at the University of Liège. He is also coordinator of the Department of Sports Medicine and Traumatology (SportS2), recognised as FIFA (Fédération International de Football Association) Medical Centre of Excellence, IOC (International Olympic Committee) Research Centre for Injury Prevention and Protection of Athlete Health and FIMS (International Federation of Sports Medicine) Collaborative Center of Sports Medicine. He is a member of the Medical Commission of the Belgian Olympic and Interfederal Committee (BOIC). He received many prestigious rewards for his scientific and clinical work in the field of Physical and Rehabilitation medicine.

 

SUMMARY OF THE TOPIC
Tendinopathy manifests as pain in the tendon and diminished performance, sometimes accompanied by tendon swelling. While clinical assessment is the primary method for diagnosis, ultrasonography and magnetic resonance imaging can provide additional precision. Widely prevalent, tendinopathy ranks among the most frequently self-reported musculoskeletal conditions in both physical laborers and athletes. However, conducting comprehensive epidemiological studies on tendinopathy proves challenging due to diverse sports cultures and habits across different countries.
The etiology of tendinopathy appears to be multifaceted, involving intrinsic and extrinsic factors. Although the role of inflammation is a subject of debate, the absence of inflammatory cells does not negate the involvement of inflammatory mediators. Various theories attempt to elucidate pain and chronicity mechanisms, yet these mechanisms largely remain unknown. Conventional treatments are typically applied empirically to alleviate pain and inflammation but do not alter the tendon’s histological structure. Despite their widespread use, these treatments are not entirely satisfactory, with recurrent symptoms being commonplace.
Promisingly, several new treatments for tendinopathy are currently under development; however, limited evidence supports their efficacy in clinical practice.

Data

24 Gen 2024
Expired!

Ora

19:00

Luogo

Online
QR Code